ACM Research, Inc. (ACMR) Stock Analysis
Is ACMR a good investment?
ACM Research, Inc. (ACMR) has a Plutrex AI rating of 68.5/100 as of October 01, 2026, indicating a Buy consensus. The stock is not classified as halal-compliant. Key strength: Balance sheet fortress: $1.44B cash with D/E of 0.11 (52.8% below industry average of 0.233) — best-in-class leverage profile in the peer group, providing exceptional downside protection and multi-year strategic optionality. Main concern: Valuation mismatch persists: ACMR trades at 38.98x PE (26.5% premium to 30.81x industry) while being a growth laggard on every forward metric (41.2% vs. 57.56% next-year EPS growth; 39.5% vs. 68.26% 5-year EPS growth) and a profitability laggard (ROE 10.55% vs. 54.59%; operating margin 17% vs. 50.54%) — premium price for below-average fundamentals creates meaningful multiple compression risk.
Investment Summary
ACM Research (ACMR) at $80.92 presents a nuanced hold: genuine revenue momentum (36% YoY growth) and a near-PEG-1.0 valuation (0.99) coexist with a 26.5% PE premium (38.98x vs. 30.81x industry average), inferior profitability vs. peers (ROE 10.55% vs. 54.59% industry; operating margin 17.0% vs. 50.54% industry), and forward EPS growth (41.2% next year; 39.5% 5-year) that is 28-42% below the semiconductor sector average. The news environment is constructive — analyst EPS estimate revisions are trending upward, backlog disclosures from ACM Shanghai are ongoing (confirming order visibility), and multiple Wall Street analysts maintain Buy ratings with a $118 consensus target implying 45.8% upside. However, the stock has barely moved ($80.67 → $80.92, +0.3%) and no material metric has shifted over the past week, anchoring this assessment firmly to the prior Hold conclusion. Strong balance sheet ($1.44B cash, D/E 0.11) limits downside, but the valuation mismatch — premium multiple, sub-peer growth and profitability — remains unresolved. Risk/reward improves meaningfully only in the $72-$77 entry zone.
Key Strengths
- Balance sheet fortress: $1.44B cash with D/E of 0.11 (52.8% below industry average of 0.233) — best-in-class leverage profile in the peer group, providing exceptional downside protection and multi-year strategic optionality
- Analyst momentum is positive: multiple Wall Street analysts revised EPS estimates higher, maintain Buy ratings, and consensus target of $118 implies 45.8% upside; PEG of 0.99 (4.4% below 1.032 industry average) confirms growth-adjusted value on a standalone basis
- Confirmed revenue execution: 36.0% YoY revenue growth supported by backlog disclosures from ACM Shanghai (September 2026) and AI-driven semiconductor demand tailwinds, with strong order visibility reducing near-term revenue risk
Key Concerns
- Valuation mismatch persists: ACMR trades at 38.98x PE (26.5% premium to 30.81x industry) while being a growth laggard on every forward metric (41.2% vs. 57.56% next-year EPS growth; 39.5% vs. 68.26% 5-year EPS growth) and a profitability laggard (ROE 10.55% vs. 54.59%; operating margin 17% vs. 50.54%) — premium price for below-average fundamentals creates meaningful multiple compression risk
- Earnings quality concern: YoY EPS decline of -28.8% despite 36% revenue growth implies material share dilution or structural earnings drag, directly undermining credibility of the 41.2% forward EPS growth projection; negative FCF of -$120M adds to quality concerns despite strong revenue momentum
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
ACMR's standalone fundamentals are solid but not exceptional. Gross margin of 43.84% is reasonable for semiconductor equipment but 18.3 percentage points below the 62.14% industry average, reflecting the inherent margin structure disadvantage vs. fabless/IP peers. Operating margin of 16.98% (vs. 50.54% industry average — a 66.4% discount) and net margin of 14.48% (vs. 44.63% industry — 67.6% discount) confirm the structural profitability gap. ROE of 10.55% (vs. 54.59% industry — 80.7% discount) is the most alarming peer comparison, indicating the business generates less than one-fifth the equity returns of the average semiconductor company. Debt-to-equity of 0.11 (vs. 0.233 industry average) is ACMR's clearest balance sheet advantage, supported by $1.44B in cash. Negative FCF of -$120M is a yellow flag but manageable given the cash buffer. On valuation, PE of 38.98x sits at a 26.5% premium to the 30.81x peer average — unjustified given below-average growth (forward EPS growth of 41.2% vs. 57.56% industry; 5-year 39.5% vs. 68.26% industry) and below-average profitability. PEG of 0.99 offers marginal growth-adjusted relief but only a 4.4% discount to the 1.032 industry PEG — not enough to offset the PE premium. Revenue growth of 36.0% is strong in absolute terms but still 63.9% below the 99.77% industry average. Forward EPS growth estimates are being revised upward by analysts, which is constructive, but the trailing YoY EPS decline of -28.8% (vs. 36% revenue growth) remains unexplained — likely dilution-driven — and creates credibility risk around the 41.2% forward projection. Additional metrics: PE Ratio: 38.98
News Sentiment
ACM Research is quietly building momentum on Wall Street, even as its stock trades well below what analysts believe it's worth. The semiconductor equipment maker — which helps chipmakers clean and process wafers — has been drawing attention from analysts who see a big gap between its current price of around $81 and their average target of $118, representing potential gains of more than 45%. Multiple Wall Street firms have been revising their earnings estimates higher for ACMR, a signal that the financial community sees the company's prospects improving. That optimism is reinforced by strong AI-driven demand across the chip sector, with ACMR appearing on lists of semiconductor stocks benefiting from surging technology sales. The company's Chinese subsidiary, ACM Research Shanghai, recently disclosed fresh backlog data through late September 2026, giving investors a clearer picture of the order pipeline fueling future revenue. Analysts have been publicly making the case that ACMR may be nearing a price floor, with one note arguing the stock is positioned for a rebound. While the company carries impressive revenue growth of 36% year-over-year and a war chest of $1.44 billion in cash, skeptics point to profit margins that trail the broader semiconductor industry and a valuation premium that isn't fully supported by growth metrics. For patient investors, the story comes down to whether ACMR can convert its revenue momentum into the kind of earnings growth that would justify — and eventually expand — its current multiple.
Risk Assessment
Primary risk: multiple compression. ACMR's 26.5% PE premium (38.98x vs. 30.81x peers) is not supported by its growth profile (41.2% next-year EPS growth vs. 57.56% industry) or profitability (ROE 10.55% vs. 54.59% industry). If the market re-rates ACMR to the peer average PE of 30.81x, the implied price would be ~$64 — a 21% drawdown from current levels. Secondary risk: EPS execution. The -28.8% trailing YoY EPS decline paired with negative FCF of -$120M raises questions about whether the 41.2% forward EPS growth is achievable without further dilution. If forward estimates are cut, the current PE premium becomes indefensible. Geopolitical/regulatory risk: ACMR derives significant revenue from China operations (ACM Shanghai is dual-listed on the Shanghai Stock Exchange), creating exposure to US-China trade restrictions, export controls, and regulatory compliance burdens. Mitigation: The $1.44B cash buffer (D/E 0.11) provides a substantial downside cushion. Analyst consensus target of $118 (45.8% upside) from multiple Buy-rated analysts provides a credible bull case if EPS revisions continue upward. Entry in the $72-$77 zone reduces valuation risk by pricing ACMR closer to a peer-equivalent multiple.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is ACMR a halal stock?
No, ACM Research, Inc. (ACMR) is currently not classified as halal by AAOIFI criteria.
What is Plutrex's AI rating for ACMR?
ACM Research, Inc. (ACMR) has a Plutrex AI rating of 68.5/100 with a Buy consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is ACMR a good investment?
According to Plutrex AI, ACMR has a Buy rating (68.5/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in ACMR?
US stocks like ACMR can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. Plutrex provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in ACMR?
Plutrex AI identifies the main risks for ACMR by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.